Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

2,5-Bis(1-Aziridinyl)-3-(2-Carbamoyloxy-1-Methoxyethyl)-6-Methyl-1,4-Benzoquinone

    • Product Name 2,5-Bis(1-Aziridinyl)-3-(2-Carbamoyloxy-1-Methoxyethyl)-6-Methyl-1,4-Benzoquinone
    • Alias Mitomycin C
    • Einecs 259-453-6
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    219798

    Chemical Name 2,5-Bis(1-Aziridinyl)-3-(2-Carbamoyloxy-1-Methoxyethyl)-6-Methyl-1,4-Benzoquinone
    Molecular Formula C16H22N4O5
    Molecular Weight 350.37 g/mol
    Appearance Yellow powder
    Melting Point 184-186°C
    Solubility Soluble in DMSO and methanol
    Cas Number 51-20-7
    Purity Typically ≥98% (HPLC)
    Storage Conditions Store at 2-8°C, protected from light
    Synonyms Mitomycin C derivative
    Iupac Name 2,5-bis(aziridin-1-yl)-3-(2-carbamoyloxy-1-methoxyethyl)-6-methylcyclohexa-2,5-diene-1,4-dione
    Hazard Classification Toxic; handle with care
    Usage Pharmaceutical intermediate, research chemical

    As an accredited 2,5-Bis(1-Aziridinyl)-3-(2-Carbamoyloxy-1-Methoxyethyl)-6-Methyl-1,4-Benzoquinone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging is a sealed amber glass bottle containing 5 grams of 2,5-Bis(1-Aziridinyl)-3-(2-Carbamoyloxy-1-Methoxyethyl)-6-Methyl-1,4-Benzoquinone, labeled and tamper-evident.
    Shipping **Shipping Description:** 2,5-Bis(1-Aziridinyl)-3-(2-Carbamoyloxy-1-Methoxyethyl)-6-Methyl-1,4-Benzoquinone should be shipped in tightly sealed containers, protected from light and moisture. It requires transport as a hazardous chemical, following local and international regulations (such as IATA/IMDG), accompanied by appropriate safety documentation and labeling indicating its potentially toxic and reactive nature.
    Storage Store **2,5-Bis(1-Aziridinyl)-3-(2-Carbamoyloxy-1-Methoxyethyl)-6-Methyl-1,4-Benzoquinone** in a tightly sealed container, away from light and moisture, in a cool, dry, and well-ventilated area. Keep separate from strong oxidizers and acids. Handle under an inert atmosphere if sensitive to air. Label container clearly and use appropriate PPE when handling.
    Application of 2,5-Bis(1-Aziridinyl)-3-(2-Carbamoyloxy-1-Methoxyethyl)-6-Methyl-1,4-Benzoquinone

    Applications of 2,5-Bis(1-Aziridinyl)-3-(2-Carbamoyloxy-1-Methoxyethyl)-6-Methyl-1,4-Benzoquinone in Industrial Manufacturing

    As a chemical raw material manufacturer, we supply 2,5-Bis(1-Aziridinyl)-3-(2-Carbamoyloxy-1-Methoxyethyl)-6-Methyl-1,4-Benzoquinone for critical downstream manufacturing in several highly regulated sectors. This compound supports advanced synthesis requirements for specialty chemicals, high-performance coatings, and pharmaceutical intermediates. Below, we outline its core industrial application scenarios, processing roles, compliance benchmarks, recommended incorporation ratios, stages in downstream integration, and finished product groups.

    1. Specialty Antineoplastic API Synthesis

    This material supports the multi-step synthesis of anticancer active pharmaceutical ingredients, serving as an electrophilic intermediate in the construction of DNA-alkylating agent scaffolds. Its aziridinyl moieties undergo direct participation in nucleophilic substitution and ring-opening reactions, critical for final API core assembly. Chemists rely on precision charge-transfer properties to direct selectivity in building complex heterocyclic drugs targeting leukemia and lymphoma. Customers require high purity and traceability from upstream synthesis batches to comply with registration of pharmaceutical products.

    Industry compliance standards

    • ICH Q7 GMP for API manufacturing
    • USP, Ph. Eur. raw material monograph conformity (where applicable)
    • FDA 21 CFR Part 211 (Finished Pharmaceuticals)
    • Drug Master File (DMF) supporting documentation for US and EU markets

    Typical usage ratio

    • 0.10–0.35 molar equivalents per main heterocycle formation step; adjusted for stoichiometry and batch scale during lead intermediate coupling

    Downstream process integration

    • Direct addition in the late- or penultimate-stage coupling reaction under anhydrous conditions, followed by in situ purification or quenching dependent on the synthetic route

    Final product types

    • Cytotoxic chemotherapy drug APIs (e.g., bi-functional alkylating agents, nitrogen mustards)
    • Final injectable oncology medicines

    2. Advanced Crosslinker for Epoxy and Polyurethane Coatings

    Manufacturers of industrial coatings incorporate this compound as a high-activity crosslinker, leveraging the reactivity of the aziridinyl rings to enhance chemical and abrasion resistance in both epoxy and polyurethane film systems. This leads to improved durability and aggressive media resistance for coatings used in aerospace, electronics, and high-wear automotive parts. Its controlled functional group density allows formulators to fine-tune hardness and flexibility, meeting demanding end-user requirements for protective linings and component encapsulation.

    Industry compliance standards

    • ISO 12944 for protective paint systems
    • REACH Annex XVII chemical safety compliance
    • VOC limits as per EU Directive 2004/42/EC for coatings
    • RoHS Directive restrictions (for electronics and electrical applications)

    Typical usage ratio

    • 0.5–2.5 wt% versus total resin solids, adjusted according to crosslink density targets and mechanical test results in QC validation

    Downstream process integration

    • Post-addition in final formulation blending prior to curing, ensuring controlled aziridine group reactivity with resin matrix hydroxyl, carboxyl, or amine functionalities; often with controlled mixing speeds and temperature profiles

    Final product types

    • Anti-corrosive metal coatings
    • PCB conformal coatings
    • Automotive clear coats
    • Industrial polyurethane flooring sealers

    3. Functional Monomer for Specialty Polymer Synthesis

    Polymer research and manufacturing facilities select this molecule for use as a specialty monomer in the preparation of functionalized copolymers and block polymers requiring integrated aziridine and benzoquinone sites. The structure enables covalent grafting of biomolecules or small-molecule modifiers post-polymerization, supporting the creation of specialty resins for membrane technology, biomedical devices, and custom adhesive systems. Process engineers monitor monomer distribution and reactivity through in-process NMR and GPC, maintaining narrow molecular weight dispersity and precise branching.

    Industry compliance standards

    • ISO 9001:2015 Quality Management in chemical synthesis
    • USP Class VI (biomedical device materials, where applicable)
    • FDA CFR Title 21 Part 177 (indirect food contact, evaluated per application)
    • REACH substance evaluation and notification (for new polymer applications)

    Typical usage ratio

    • 1–10 mol% relative to overall monomer mix, with fine adjustment for targeted copolymer ratios and desired reactive group density

    Downstream process integration

    • Co-dosing during bulk, solution, or emulsion polymerization steps; monomer sequence and proportion controlled by automated dosing systems linked to real-time spectroscopic monitoring

    Final product types

    • Ion-exchange membranes
    • Custom biomedical hydrogels
    • Pressure-sensitive adhesives for electronics and diagnostics
    • Reactive functional resins for filtration or medical device coatings

    4. Intermediate in Electrophilic Dye and Marker Manufacturing

    Leading dye and labeling agent producers use this compound as a building block for the synthesis of specialty chromophores and bioactive labeling reagents, including aziridinyl-activated benzoquinone dyes for nucleic acid, protein, or enzyme detection. The unique molecular layout facilitates controlled introduction of reactive sites for subsequent derivatization with application-specific tethers, impacting detection sensitivity in biotechnological assays and diagnostic kits. Stringent quality control tests for trace impurities and batch consistency are enforced, as product grades are often destined for regulated research and clinical supply chains.

    Industry compliance standards

    • ISO 13485 for medical device and diagnostic reagent production
    • OECD GLP for analytical reagent manufacturing
    • REACH Annex III for pigment and dye intermediates
    • FDA QSR for in vitro diagnostic raw materials

    Typical usage ratio

    • 0.2–1.0 eq relative to chromophore precursor, scaled according to desired substitution patterns and labeling capacity

    Downstream process integration

    • Reactant incorporation at the key substitution or bridging step within chromophore or probe synthesis; reaction parameters controlled for purity and yield, with downstream purification via chromatography

    Final product types

    • Electrophilic labeling dyes for life science kits
    • Covalent fluorescent probes
    • Analytical reagents for DNA/RNA detection
    • Bioactive enzyme and protein markers
    Free Quote

    Competitive 2,5-Bis(1-Aziridinyl)-3-(2-Carbamoyloxy-1-Methoxyethyl)-6-Methyl-1,4-Benzoquinone prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    2,5-Bis(1-Aziridinyl)-3-(2-Carbamoyloxy-1-Methoxyethyl)-6-Methyl-1,4-Benzoquinone: A Manufacturer’s Perspective

    Understanding the Core Technology

    Decades of pushing the boundaries in the synthesis of benzoquinone derivatives guided us toward refining a reliable, scalable process for 2,5-Bis(1-Aziridinyl)-3-(2-Carbamoyloxy-1-Methoxyethyl)-6-Methyl-1,4-Benzoquinone. Those in pharmaceuticals and specialty industries often ask what shapes the quality and consistency of this complex molecule. The answer lives in careful control at every step: reagent selection, temperature regulation, and reaction clean-up. This isn’t the sort of compound that leaves much room for shortcuts. Even small slips during aziridine ring integration can derail purity or lead to byproduct formation. So, experience counts, both at the benchtop and on the plant floor.

    Product Model and Specifications Grown from Real Use

    We don’t think in catalog numbers here, preferring instead to look at our material as batches with real histories and fingerprints. Key metrics start with purity—our standard production lots consistently reach percent levels high enough to satisfy not only analytical benchmarks but strict downstream expectations in research and pre-clinical development. Each batch profile tells a story, written in elements such as HPLC traces, melting points, and residual solvent levels. True, spectroscopy shines when it comes to confirming structure: Nuclear Magnetic Resonance (NMR) and Mass Spectrometric signatures remain non-negotiable signposts of genuine material. Several partners value our willingness to offer detailed Certificates of Analysis reflecting each lot’s story, as these reports build trust and let customers plan their next steps with confidence.

    Why This Compound Matters Now

    Field chemists appreciate that no compound exists in a vacuum. Benzoquinones with aziridine rings and functional carbamoyloxy groups serve as valuable intermediates in antineoplastic research. Synthetic researchers leverage our material for its crosslinking power, its reactivity, and the ease with which it opens further transformation paths. Others see it as a scaffold—a launching point for small-molecule drug libraries, diagnostic tool design, or chemical biology probes. From a commercial standpoint, we continue to observe new papers and patent filings that focus attention on this family of modulated benzoquinones and their application in DNA-interactive therapies.

    At the bench, chemists see difference in every subtle reactivity. They notice the tone of the quinone’s yellow and sometimes deep orange coloration as a quick visual guide. For years, we listened as researchers described how alternative benzoquinone derivatives proved too unstable, too sensitive to light, or fell short due to impurity profiles. They described trouble with purification or batch-to-batch inconsistency. Over time, we learned to optimize solvent choices and crystallization parameters, reducing persistent aromatic impurities and minimizing unreacted starting materials. Those improvements show up not just in neat certificates but when researchers run their first HPLC and see clean, symmetric peaks.

    Major Differences from More Common Benzoquinones

    Exploring the contrasts with simple benzoquinones (such as 1,4-benzoquinone or p-benzoquinone), our aziridinyl-methoxyethyl-methyl combination brings some useful twists. The aziridine rings provide both strain and nucleophilic closure, which synthetic chemists exploit for targeted derivatization. The carbamoyloxy and methoxyethyl groups further shape reactivity and solubility. Compared to 2,5-diamino-1,4-benzoquinone or chlorinated analogues, this molecule stands out by avoiding excessive redox lability and by tempering hydrolysis.

    We’ve encountered customers who, for certain projects, sought the unmodified benzoquinone core only to find that the resulting intermediates decomposed during downstream reactions. By contrast, our substituted molecule maintains structural integrity during post-synthetic modifications and usually carries through aqueous workups without fragmentation or polymerization. This distinction matters at scale, where lost material means lost time and money. More than once, an end-user’s feedback prompted us to review trace salt removal or adjust silica gel pre-treatment. In this way, our production practices move hand in hand with real-life research setbacks.

    What Our Process Teaches the Industry

    Scaling up from gram-scale glassware to multi-kilo batch reactors always uncovers stress points. We faced headaches with batch exotherms as aziridine insertion ramped up reactivity. By redesigning temperature control and always calculating buffer capacity in advance, we stabilized yields and protected reactor operators. The learning didn’t end there. Some solvents that worked in the lab proved disastrous at scale—triggering emulsions or giving sluggish phase separation. The hard lessons get reflected in every new batch sheet, parsed over by our chemists for patterns and opportunities for further improvement.

    Quality never stands still. Every year introduces fresh demands as research approaches shift or new regulatory scrutiny emerges. We take stability studies seriously, storing multiple lots under accelerated and real-time conditions: ambient, refrigerated, desiccated. Customers appreciate our habit of providing real-time data, showing what happens to this benzoquinone after three, six, or twelve months. These stability profiles mean both a quicker project start and fewer surprises in translational pipelines. Pointing to proven stability builds trust with collaborators—especially those trying to forecast timelines for preclinical studies or preliminary toxicology screens.

    Supporting Real-World Applications and Meeting Demands

    Applications push us to keep our material robust. Anticancer research draws the most requests, where the cross-linking potency of aziridinyl quinones can mean progress on drug-resistant cell lines or molecularly targeted agents. Synthetic flexibility allows researchers to bolt on labels, tethers, or protective groups. Many projects need precise structure-activity studies; the consistency of our batches smooths any headaches over variable results. In recent years, some customers asked for larger quantities—proof that translational research now looks beyond milligram trials. Our teams respond by scaling reactors and running extended purification campaigns, keeping impurity levels predictable at each run.

    Some of the more interesting uses emerge at the edges of discovery science. Diagnostic teams looking for small-molecule labeling handles. Chemical biologists using our benzoquinone for probe design or target validation. For these fields, it isn’t just the purity or the tight batch variation that matters, but the confidence that functional groups will perform reliably when incorporated into complex biomolecular systems.

    Addressing Batch-to-Batch Reliability and Research Challenges

    Every plant operator knows batch deviation sets off a chain reaction of delays and data re-checks. Our experience taught us to view every successful batch as a product of process discipline. Precursor storage, real-time monitoring, filtration setup—routine steps in principle, but critical in practice. Teams have put in long hours to cross-check raw materials, audit supplier quality, and stress-test our own manufacturing equipment. This is the only way to keep within tight impurity controls and avoid “rogue” batches that fail to meet customer chromatogram or spectral expectations.

    Feedback loops matter. Some researchers bring project-specific requirements—extra dryness, altered particle size, or special packaging to preserve sample integrity in transit. We accommodate where possible and see this as a sign of the complexity of modern research demands. Each adaptation points to trends: automation in high-throughput screening, ever-greater sensitivity in downstream assays, or an uptick in requests for environmentally friendly solvents during shipment. We adapt our packing, our in-process testing, and our documentation to match these changes, keeping an ear open for early-stage innovations that may soon scale up.

    Differentiating From Traders and Resellers

    Making this molecule ourselves—not just buying and repackaging—has proven its worth through hard-won experience. We see where traders often lose track of information, leaving users with missing spectral files or vague batch histories. That isn't an option here. Each lot that leaves our plant comes with a detailed dossier: analytical traces from synthesis, processing notes that record who ran each step, exact conditions, and in some cases, photographic proof of sample appearance. This transparency builds trust and, more importantly, gives researchers peace of mind. If something unexpected crops up, our chemists and plant techs can track it back through the chain, from raw material to finished bottle.

    There’s no substitute for knowing your process top to bottom. When “made to stock” traders offer the same CAS number with low cost, the difference shows up in project outcomes nearly every time. Our own batch testing revealed that off-the-shelf samples, not subjected to repeat crystallization or post-synthesis washes, often carried significant levels of halide, heavy metals, or residual solvents. Some labs saw evaporative losses or yellowing after exposure to air that we tracked to slightly elevated peroxide contamination. Real manufacturing means identifying, tracking, and correcting these issues before shipment, saving downstream teams from expensive troubleshooting.

    Continual Quality Improvement Born from the Lab and Plant

    No chemical process ever reaches perfection, but the steady application of improvement tools closes the gap between the ideal and the real. Our staff lives this mindset every day. Statistical process control charts identify long-term patterns, prompting equipment maintenance or protocol re-writes as needed. Customer complaints, rare as they are, get dissected and tracked into our next round of QA reviews. Stability failures prompt routine evaluation of desiccant choice, seal integrity, and shipping temperatures. Once we caught a misplaced barcode that nearly mixed two different lot numbers; new scanning routines and staff training closed this gap rapidly.

    Experience from emergencies also shapes long-term practices. Several years back, a surge in demand for this product during a strong research push led to extended runs with less downtime. Reactors needed accelerated cleaning cycles. Each time we noticed throughput issues or minor deviations in product appearance, a deep dive followed. These events taught us the value of redundancy—backup filtration, formal changeover logs, and inter-shift handoffs. Our team came out the other side with a tighter operation and a stronger commitment to traceability as a whole.

    Solutions for Industry Challenges and Customer Needs

    Many new entrants to benzoquinone synthesis underestimate the role environmental control plays in process integrity. Moist air, minor pH shifts, or trace levels of iron from reactor surfaces can catalyze unwanted side reactions. Our answer stays rooted in experience: tight environmental monitoring, regularly calibrated analytical tools, and strict reagent storage policies. Ongoing preventive maintenance keeps our process water and utility steam free from cross-contamination. Careful attention to these “unseen” process elements delivers batches that meet or exceed the stated analysis on every report.

    Shipping is another underestimated risk, especially for sensitive chemicals with defined stability profiles. We worked closely with shipping partners to create durable, heat-resistant packaging and to flag lots that must avoid extended customs holds. Customers with long-term storage needs benefit from our detailed guidelines—proven firsthand in our own inventory rooms over years of observation.

    Requests for documentation and compliance also rose steadily. Larger organizations and clinical-stage groups require full analytical dossiers, traceability to GMP-like standards, and long shelf life predictions. We devote resources to regulatory updates, document control, and collaboration with external auditors where needed. These steps don’t just tick boxes but reflect the shifts in modern research environments and the increasing regulatory tone of international chemical trade.

    Looking Forward: Meeting the Next Generation of Research Needs

    In the years ahead, we expect demand for aziridinylated benzoquinones to grow as research deepens into mechanism-based anticancer agents and crosslinking chemical biology probes. More projects will move from tens of milligrams to kilogram-scale lots as translational gaps close and proof-of-concept data drive scale-up. Our team is investing in process safety and product stewardship, ensuring safe expansion capacity and best-in-class documentation.

    We watch developments in green chemistry with great interest, applying principles where practical to reduce solvent waste, lower reaction temperatures, and improve overall process yields. By working directly with research partners, we continue to refine our synthesis practices—providing custom modifications, alternative salt forms, or co-crystallization partners on request. This flexibility, built on direct manufacturing experience, puts us in a strong position to serve emerging demands swiftly and reliably.

    Concluding Thoughts From the Lab Floor

    Every successful preparation of 2,5-Bis(1-Aziridinyl)-3-(2-Carbamoyloxy-1-Methoxyethyl)-6-Methyl-1,4-Benzoquinone stands as a testament to the people involved: the plant techs who load reactors, the chemists who troubleshoot and interpret spectra, and the quality team keeping standards high. Building on decades of work, we understand the stakes each time material leaves the plant—whether the end user is chasing the next breakthrough or refining an existing discovery. Much of what makes this compound valuable and distinctive comes from attention to real-world process details, and from a drive to keep raising the bar. In this way, our team serves not only the immediate scientific community but those who count on new medicines and technologies to improve lives down the road.